Taysha Gene Therapies
TSHA
TSHA
71 hedge funds and large institutions have $111M invested in Taysha Gene Therapies in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+6
Holders Change %
+9.23%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
27
Reduced
15
Closed
9
Calls
$108K
Puts
$163K
Net Calls
-$55K
Net Calls Change
-$55K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$1.63M |
| 2 |
JPMorgan Chase & Co
New York
|
$2.87M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$1.36M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$6.6M |
| 5 |
Two Sigma Investments
New York
|
$1.19M |
